Dna Damage Response Ddr Pathway | List of Frontiers open access articles

Perspective

Published on 04 Feb 2015

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies

in Cancer Genetics

Olga M. Shatnyeva
Hinrich P. Hansen
Katrin S. Reiners
Maike Sauer
Maulik Vyas
Elke Pogge von Strandmann

Frontiers in Genetics

doi 10.3389/fgene.2015.00011

8,717 views
6 citations

Review

Published on 08 Oct 2024

Emerging roles of cancer-associated histone mutations in genomic instabilities

in Cancer Cell Biology

Priyanka Yadav
Ronit Jain
Rajesh Kumar Yadav

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1455572

5,464 views
8 citations

Original Research

Published on 13 May 2022

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors

in Cancer Molecular Targets and Therapeutics

Peng Gu
Liting Xue
Chunyan Zhao
Wenjing Li
Zhen Jiang
Aiguo Liu
Tingting Li
Lu Liu
Markus Decker
Xiaoxuan Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.885186

7,457 views
11 citations

Review

Published on 05 May 2020

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers

in Molecular and Cellular Oncology

Martin Liptay
Joana S. Barbosa
Sven Rottenberg

Frontiers in Oncology

doi 10.3389/fonc.2020.00670

14,045 views
21 citations

Original Research

Published on 02 Nov 2021

APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells

in Molecular and Cellular Pathology

Md Akram Hossain
Yunfeng Lin
Garrett Driscoll
Jia Li
Anne McMahon
Joshua Matos
Haichao Zhao
Daisuke Tsuchimoto
Yusaku Nakabeppu
Jianjun Zhao

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.738502

9,267 views
19 citations

Original Research

Published on 18 Jun 2021

Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma

in Cancer Immunity and Immunotherapy

Chaozheng Zhou
Anqi Lin
Manming Cao
Weimin Ding
Weiming Mou
Ningyi Guo
Zhenyu Chen
Jian Zhang
Peng Luo

Frontiers in Immunology

doi 10.3389/fimmu.2021.634741

8,346 views
37 citations

Articles

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies

Emerging roles of cancer-associated histone mutations in genomic instabilities

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers

APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells

Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma